Meta Biomed Co. Ltd (059210) — Cash Flow Quality Index
Meta Biomed Co. Ltd (059210) has a Cash Flow Quality Index of 0.24x as of September 2025. Operating cash flow of ₩1.05 Billion is below net income of ₩4.46 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of Meta Biomed Co. Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Meta Biomed Co. Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Meta Biomed Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Meta Biomed Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Meta Biomed Co. Ltd (2011–2024)
Year-by-year earnings quality comparison for Meta Biomed Co. Ltd. For live market cap and the full company financial profile, see 059210 stock market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.01x | ₩22.63 Billion | ₩22.32 Billion | ▼ -2.6% |
| 2023 | 1.04x | ₩10.22 Billion | ₩9.82 Billion | ▼ -70.1% |
| 2022 | 3.49x | ₩9.16 Billion | ₩2.63 Billion | ▲ +198.0% |
| 2021 | 1.17x | ₩11.14 Billion | ₩9.52 Billion | ▲ +36.6% |
| 2019 | 0.86x | ₩2.86 Billion | ₩3.35 Billion | ▼ -87.3% |
| 2016 | 6.72x | ₩5.03 Billion | ₩748.74 Million | ▲ +32.1% |
| 2015 | 5.09x | ₩4.93 Billion | ₩969.74 Million | ▲ +197.5% |
| 2013 | 1.71x | ₩3.71 Billion | ₩2.17 Billion | ▲ +4.0% |
| 2012 | 1.64x | ₩3.83 Billion | ₩2.33 Billion | ▼ -52.8% |
| 2011 | 3.48x | ₩4.10 Billion | ₩1.18 Billion | — |